Ovarian Cancer Clinical Trial

Clinical Trial Finder Ovarian Cancer Trials

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

See Locations Near You

Summary

This study will determine the maximum-tolerated dose (MTD) for oral bosutinib when used in combination with pemetrexed. The MTD is the highest dose of bosutinib with pemetrexed that can be given without causing severe side effects. This study will also test the safety of this combination and see what effects (good or bad) it has on participants and their cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pathologically or cytologically proven advanced, metastatic non-squamous non-small cell lung cancer, pleural malignant mesothelioma, bladder or urethral cancer, ovarian cancer, primary peritoneal cancer, thymoma and thymic cancer and uterine cervical cancer.
Measurable disease
Life expectancy of greater than 3 months.
Ability to take folic acid, vitamin B12, and dexamethasone according to protocol.

Exclusion Criteria:

- Untreated or symptomatic brain metastases.

Study is for people with:

Ovarian Cancer

Phase:

Phase 1

Estimated Enrollment:

6

Study ID:

NCT03023319

Recruitment Status:

Completed

Sponsor:

Nagla Abdel Karim

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Augusta University Georgia Cancer Center
Augusta Georgia, 30912, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Phase:

Phase 1

Estimated Enrollment:

6

Study ID:

NCT03023319

Recruitment Status:

Completed

Sponsor:


Nagla Abdel Karim

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Promising Immunotherapy Trials for Ovarian Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider